Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic analysis of high-risk smoldering multiple myeloma.

Haematologica - 1 Sept 2012

López-Corral Lucía, Mateos María Victoria, Corchete Luis A, Sarasquete María Eugenia, de la Rubia Javier, de Arriba Felipe, Lahuerta Juan-José, García-Sanz Ramón, San Miguel Jesús F, Gutiérrez Norma C

Abstract excerpt

Smoldering myeloma is an asymptomatic plasma cell dyscrasia with a heterogeneous propensity to progress to active myeloma. In order to investigate the biology of smoldering myeloma patients with high risk of progression, we analyzed the genomic characteristics by FISH, SNP-arrays and gene expression profile of a group of patients with high-risk smoldering myeloma included in a multicenter randomized trial....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to In Situ Hybridization, Fluorescence

Share to Multiple Myeloma

Share to Oligonucleotide Array Sequence Analysis

Share to Plasma Cells

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 22331267
DOI: 10.3324/haematol.2011.060780
PMCID: PMC3436247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic analysis of high-risk smoldering multiple myeloma.PMID 22331267Read ↗

Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma.Semantic proximity Read ↗

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionSemantic proximity Read ↗

Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma.Semantic proximity Read ↗

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.Semantic proximity Read ↗

Genomic Profiling to Contextualize the Results of Intervention for High-Risk Smoldering MyelomaSemantic proximity Read ↗

Genomic patterns of progression in smoldering multiple myeloma.Semantic proximity Read ↗

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.Semantic proximity Read ↗

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosisSemantic proximity Read ↗

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.Semantic proximity Read ↗

Evolutionary biology of high-risk multiple myeloma.Semantic proximity Read ↗

Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical OutcomesSemantic proximity Read ↗

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.